Regulation of blood coagulation

Slides:



Advertisements
Similar presentations
Coagulation (the basics) and recombinant Factor VIIa Mechanism of Action Jerrold H. Levy, MD Emory University School of Medicine and Emory Healthcare Atlanta,
Advertisements

Blood coagulation involves a biological amplification system in which relatively few initiation substances sequentially activate by proteolysis a cascade.
Blood S-J Tsai Department of Physiology. Composition Composed of cells (erythrocytes, leukocytes, and platelets) and plasma (the liquid in which the cells.
Scheme of Coagulation F XIIF XIIa F XIF XIa F IX F X F IXa F VIIaF VII Extrinsic System Tissue damage Release of tissue thromboplastine (F III) Intrinsic.
PHYSIOLOGIC CONTROL OF HEMOSTASIS MLAB Coagulation Keri Brophy-Martinez.
Platelets. Fig Hemostasis the process by which the bleeding is stopped from broken vessels. steps involved: Vascular spasm. Platelets plug formation.
From: Treatment of Excessive Bleeding in Jehovah's Witness Patients after Cardiac Surgery with Recombinant Factor VIIa (NovoSeven®) Anesthes. 2003;98(6):
Revised model of coagulation
Immune pathogenesis of apoptosis of CD34 multipotential hematopoietic cells in acquired aplastic anemia. Antigens are presented to T lymphocytes by antigen-presenting.
Algorithm for the pharmacotherapy of social anxiety disorder
A heterogeneous group of platelet defects can result in an abnormal secondary wave of platelet aggregation in response to ADP and epinephrine, and diminished.
Immunoglobulin heavy-chain (IGHC) gene complex
Kaplan-Meier plots of time from platelet transfusion to first Grade 2 or higher bleeding for each platelet characteristic. A. Time from first platelet.
Activation of the Hemostatic System During Cardiopulmonary Bypass
Activation of the Hemostatic System During Cardiopulmonary Bypass
Overview of hybrid capture preparation for sequencing
(Reprinted by permission from Macmillan Publishers Ltd
(From Beutler E, Meerkreebs G,705 with permission from the Massachusetts Medical Society.) Source: Chapter 42. Disorders of Iron Metabolism, Williams Hematology,
Effector mechanisms by which drugs mediate a positive direct antiglobulin test. Relationships of drug, antibody-combining site, and red blood cell membrane.
Estimated fraction of the various forms of secondary ITP based on clinical experience of the authors. The incidence of Helicobacter pylori (HP) ranges.
(Used with permission from Lichtman’s Atlas of Hematology, www
Ligand- and signal-activated transcription factors (represented by the round and the rectangular symbols, respectively) can bind to the promoter regions.
(Reproduced with permission from Lau TL, Kim C, Ginsberg MH, et al
General Principles of Hemostasis Kristine Krafts, M.D.
Illumina library construction and sequencing process
Volume 62, Issue 3, Pages (September 2002)
Normal voiding cystourethrograms
Platelet calcium homeostasis
Pancreatic lobule. Grossly and microscopically normal pancreatic tissue has a lobular architecture. The majority of the lobule is composed of acinar tissue.
YAG laser anterior capsulotomy for capsular phimosis
A standard epidural order form.
Liquefactive necrosis of the brain
Amino acid sequence and tentative structure for human prepro factor IX
Nutrient or ion regulation of hormone release
Advanced stage non–small cell lung cancer treatment algorithm
Pathways regulating autophagy
Platelets contain separate and distinct α-granule populations
A. Antiphospholipid antibody syndrome
Models of Fibrin Generation
Model of the function of the protein C anticoagulant pathway
(Used with permission from Lichtman’s Atlas of Hematology, www
Drugs Used in Coagulation Disorders
Color Doppler of right kidney—longitudinal views
(Used with permission from Lichtman's Atlas of Hematology, www
Evaluation of patients for inherited abnormalities in platelet number or function. The major and well-recognized entities are shown here. A reduced platelet.
What is a Blood Clot? 9/18/2018 MEDC 604 Anti-coagulants.
Regulation of monocyte procoagulant activity in acute myocardial infarction: role of tissue factor and tissue factor pathway inhibitor-1 by Ilka Ott, Martin.
Hemodynamic disorders (1 of 3)
and anti-thrombotic pharmocology Tom Williams
Coagulation and Anti-coagulation
Modulation of hemostatic mechanisms in bacterial infectious diseases
Perioperative management of the bleeding patient
Polyphosphates rock! A role in thrombosis?
Coagulation, fibrinolysis, and platelet activation in patients undergoing open and endovascular repair of abdominal aortic aneurysm  Robert S.M. Davies,
Volume 110, Issue 8, Pages (April 2016)
Thrombin generation: biochemical possibilities and clinical reality
Coagulation and innate immune responses: can we view them separately?
by Cornelis van 't Veer, Neal J. Golden, and Kenneth G. Mann
Mechanism of factor VIIa–dependent coagulation in hemophilia blood
Figure 1 The coagulation system
Volume 137, Issue 6, Pages (December 2009)
Thrombin During Cardiopulmonary Bypass
General Principles of Hemostasis Kristine Krafts, M.D.
Thrombosis and Inflammatory Bowel Disease
Naturally Occurring Inhibitors
Chapter 15 Arterial and Venous Thrombosis and Thrombolysis
Hemostasis Hemostasis depends on the integrity of Blood vessels
Editorial III British Journal of Anaesthesia
Factor VIIa interaction with EPCR modulates the hemostatic effect of rFVIIa in hemophilia therapy: mode of its action by Shiva Keshava, Jagan Sundaram,
How I treat disseminated intravascular coagulation
Presentation transcript:

Regulation of blood coagulation Regulation of blood coagulation. Coagulation is initiated by a tissue factor (TF)–factor VIIa complex that can activate factor IX or factor X. At high TF concentrations, factor X is activated primarily by the TF-VIIa complex, whereas at low TF concentrations, the contribution of the factor IXa–factor VIIIa complex to the activation of factor X becomes more pronounced. Coagulation is maintained through the activation by thrombin of factor XI. The coagulation system is regulated by the protein C pathway. Thrombin activates protein C. Together with protein S, activated protein C (APC) is capable of inactivating factors Va and VIIIa, which results in a downregulation of thrombin generation and consequently in an upregulation of the fibrinolytic system. The activity of thrombin is controlled by the inhibitor antithrombin. The solid arrows indicate activation and the broken arrows inhibition. Source: Hereditary Thrombophilia, Williams Hematology, 9e Citation: Kaushansky K, Lichtman MA, Prchal JT, Levi MM, Press OW, Burns LJ, Caligiuri M. Williams Hematology, 9e; 2015 Available at: http://accessmedicine.mhmedical.com/DownloadImage.aspx?image=/data/books/1581/kau_ch130_f001.png&sec=108084639&BookID=1581&ChapterSecID=108084622&imagename= Accessed: November 08, 2017 Copyright © 2017 McGraw-Hill Education. All rights reserved